Page 80 - rcv31n3.vp

Guías sí, vías no Revista Uruguaya de Cardiología
Pablo Álvarez Rocha Volumen 31 | nº 3 | Diciembre 2016

randomised controlled trial. Lancet (London, 19. Uretsky BF, Sheahan RG. Primary Prevention of
England) [Internet]. 2012 Oct 20 [cited 2016 Aug Sudden Cardiac Death in Heart Failure: Will the Solu-
21];380(9851):1387–95. Available from: http://www. tion Be Shocking? J Am Coll Cardiol [Internet]. Jour-
ncbi.nlm.nih.gov/pubmed/22932717 nal of the American College of Cardiology; 1997 Dec [ci-
ted 2016 Jun 16];30(7):1589–97. Available from:
16. Senni M, McMurray JJ V, Wachter R, McIntyre
http://linkinghub.elsevier.com/retrie-
HF, Reyes A, Majercak I, et al. Initiating sacubi-
ve/pii/S0735109797003616
tril/valsartan (LCZ696) in heart failure: results of
TITRATION, a double-blind, randomized compari- 20. Desai AS, McMurray JJ V, Packer M, Swed-
son of two uptitration regimens. Eur J Heart Fail berg K, Rouleau JL, Chen F, et al. Effect of the
[Internet]. 2016 May 12 [cited 2016 Aug 21]; Availa- angiotensin-receptor-neprilysin inhibitor LCZ696
ble from: http://www.ncbi.nlm.nih.gov/pubmed/ compared with enalapril on mode of death in heart
27170530 failure patients. Eur Heart J [Internet]. The Oxford
University Press; 2015 Aug 7 [cited 2016 Jun
17. Langenickel TH, Tsubouchi C, Ayalasomayaju-
15];36(30):1990–7. Available from: http://www.
la S, Pal P, Valentin M-A, Hinder M, et al. The
ncbi.nlm.nih.gov/pubmed/26022006
effect of LCZ696 (sacubitril/valsartan) on amyloid-b
concentrations in cerebrospinal fluid in healthy sub- 21. McMurray JJ V., Packer M, Desai AS, Gong J,
jects. Br J Clin Pharmacol [Internet]. 2016 May [ci- Lefkowitz MP, Rizkala AR, et al. Dual angioten-
ted 2016 Jun 14];81(5):878–90. Available from: sin receptor and neprilysin inhibition as an alternati-
http://www.ncbi.nlm.nih.gov/pubmed/26663387 ve to angiotensin-converting enzyme inhibition in
patients with chronic systolic heart failure: rationale
18. Swedberg K, Komajda M, Böhm M, Borer JS,
for and design of the Prospective comparison of
Ford I, Dubost-Brama A, et al. Ivabradine and
ARNI with ACEI to Determine Impact. Eur J Heart
outcomes in chronic heart failure (SHIFT): a rando-
Fail [Internet]. 2013 Sep [cited 2016 Jun
mised placebo-controlled study. Lancet [Internet].
16];15(9):1062–73. Available from: http://doi.wi-
Elsevier; 2010 Sep [cited 2016 Aug 21];
ley.com/10.1093/eurjhf/hft052
376(9744):875–85. Available from: http://linking-
hub.elsevier.com/retrieve/pii/S0140673610611981

434